DB12866

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 2020
gptkbp:ATCCode J05AB16
gptkbp:bioavailability low (IV only)
gptkbp:CASNumber 1809249-37-3
gptkbp:category antiviral
prodrug
gptkbp:contraindication hypersensitivity to remdesivir
gptkbp:drugClass antiviral drug
gptkbp:eliminatedIn renal
gptkbp:form solution for injection
lyophilized powder
gptkbp:halfLife 1 hour (plasma)
gptkbp:hasBoxedWarning no
gptkbp:hasInChIKey RWWYLEGWBNMMLJ-YSOARWBDSA-N
gptkbp:hasMolecularFormula C27H35N6O8P
gptkbp:hasSMILES CC(C)[C@@H](NC(=O)[C@@H]1O[C@]([C@@H](O)[C@H](COP(=O)(O)O)[C@H]1O)(C)O)C#N
gptkbp:hasStorageCondition store below 30°C
gptkbp:hasUNII 53J0A3T31S
https://www.w3.org/2000/01/rdf-schema#label DB12866
gptkbp:indication gptkb:COVID-19
gptkb:Ebola_virus_infection
gptkbp:legalStatus prescription only
patented
gptkbp:manufacturer gptkb:Gilead_Sciences
gptkbp:mechanismOfAction RNA polymerase inhibitor
gptkbp:metabolism hydrolyzed to active nucleoside triphosphate
gptkbp:molecularWeight 602.6 g/mol
gptkbp:name gptkb:Remdesivir
gptkbp:pregnancyCategory Not assigned
gptkbp:proteinBinding 88-93%
gptkbp:PubChem_CID gptkb:DB12866
121304016
58828033
CHEMBL2016761
D11472
gptkbp:routeOfAdministration intravenous
gptkbp:sideEffect nausea
elevated liver enzymes
hypersensitivity
gptkbp:status FDA approved
EMA approved
gptkbp:synonym gptkb:Veklury
gptkb:GS-5734
gptkbp:target RNA-dependent RNA polymerase
gptkbp:toxicity hepatotoxicity
gptkbp:bfsParent gptkb:sodium_stibogluconate
gptkbp:bfsLayer 6